Skip to content
Unrated Drug recall · FDA · Published October 10, 2025

Endo USA Recalls Everolimus 7.5mg Tablets Due to Impurity Issues

Endo USA recalls 1,866 cartons of Everolimus tablets 7.5mg due to failed impurity specifications. Check lot numbers and expiration dates for affected units.

🇺🇸 FDA recall #D-0140-2026DrugEndo USA ›
Take action

Contact the company

Recalling firmEndo USA, Inc.9 Great Valley Pkwy · Malvern, PA 19355-1304
✎ GovInfoNow plain-language explainer

Endo USA, Inc. is recalling Everolimus tablets (7.5mg) because they failed impurity specifications for IP-C. The recall affects 1,866 cartons distributed nationwide within the United States. The record does not specify a remedy or current risk level. Read more at govinfonow.com/recall/31723-endo-usa-recalls-everolimus-7-5mg-tablets-due-to-impurity.

Source Summary by GovInfoNow · govinfonow.com/recall/31723-endo-usa-recalls-everolimus-7-5mg-tablets-due-to-impurity · Updated October 9, 2026 · FDA enforcement record: FDA #D-0140-2026

Cite this page

“Endo USA Recalls Everolimus 7.5mg Tablets Due to Impurity Issues.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31723-endo-usa-recalls-everolimus-7-5mg-tablets-due-to-impurity. Based on FDA recall #D-0140-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0140-2026%22&limit=1).

The FDA announced on Oct. 10, 2025, that Endo USA, Inc. is voluntarily recalling Everolimus Tablets 7.5mg due to failed impurity specifications. The recall affects 1,866 cartons distributed nationwide.

How to tell if you have it

  • Brand: Endo USA
  • Product: Everolimus Tablets 7.5mg
  • NDC#: 49884-127-91
  • Lot #: 550167301, Exp. Date NOV-25; 550167401, Exp. Date MAR-26; 550185101, Exp. Date MAR-26; 550205701, Exp. Date JUL-26

The hazard

The tablets are out of specification for impurity IP-C, according to the FDA.

Context

GovInfoNow's records show Endo USA, Inc. has had four other recalls since Nov. 18, 2024, including a March 13, 2026, recall of Buprenorphine Injection for crystallization risk and a Sept. 5, 2025, recall of Everolimus Tablets 5mg for impurity risks. Other recent recalls of similar products include Alembic Fesoterodine Tablets Recall (Dec. 16, 2025), Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), and Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026).

How to tell if you have this one

Look for Everolimus tablets 7.5mg in cartons containing 28 tablets (4 blister strips of 7). Check the NDC number 49884-127-91 and verify if your lot number is one of: 550167301, 550167401, 550185101, or 550205701. Check the expiration date against NOV-25, MAR-26, or JUL-26.

  • Brand
    Endo USA
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Ongoing
  • Distribution
    Nationwide within the United States
  • NDC
    49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91, 49884-128-52, 49884-128-91
Recall numberProduct, codes & lotsQuantity
D-0139-2026Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91; Lot #: 550184901, 550185001, Exp. Date MAR-26; 550189901, 550190001, Exp. Date APR-26 550203901, 550205601, Exp. Date Jul-266,655 cartons
D-0140-2026Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-127-91; Lot #: 550167301, 550167401, Exp. Date NOV-25; 550185101, Exp. Date MAR-26; 550205701, Exp. Date JUL-261,866 cartons
D-0141-2026Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91; Lot #: 550162801, Exp. Date NOV-25; 550169801, Exp. Date JAN-26935 cartons
D-0142-2026Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91; Lot #: 550172201, Exp. Date JAN-26; 550184801, Exp. Date MAR-26; 550204001, Exp. Date JUL-262,035 cartons

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Oct 10, 202512. FDA classified it Class III: Oct 29, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Endo USA recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0140-2026 (October 10, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0140-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA